"თელავის რაფერალური ჰოსპიტალი ერთადერთი მულტიპროფილური ჰოსპიტალია რეგიონის მასშტაბით. სტაციონარში 24 სთ-ის განმავლობაში უწყვეტად, სრული სპექტრით ფუნქციონირებს, როგორც დიაგნოსტიკური მიმართულება ასევე ყველა სამედიცინო სერვისი. თელავის რეფერალური ჰოსპიტალი 24 საათის განმავლობაში უზრუნველყოფს, გადაუდებელ დახმარებას ნებისმიერი სამედიცინო მიმართულებით."

During the past decade, LTD Unimed Kakheti- Telavi Referral Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LTD Unimed Kakheti- Telavi Referral Hospital" #1 sponsor was "Celgene" with 3 trials, followed by "Galapagos NV" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Kowa Research Institute, Inc." with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LTD Unimed Kakheti- Telavi Referral Hospital" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "LTD Unimed Kakheti- Telavi Referral Hospital" are "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials), "Severe Hypertriglyceridemia" (2 trials), "Arthritis, Psoriatic" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "LTD Unimed Kakheti- Telavi Referral Hospital" in a lesser frequency.

Most popular intervention types in "LTD Unimed Kakheti- Telavi Referral Hospital" are "Drug" (10 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Filgotinib" (3 trials), "Ozanimod" (3 trials), "Fenofibrate" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "LTD Unimed Kakheti- Telavi Referral Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "LTD Unimed Kakheti- Telavi Referral Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in LTD Unimed Kakheti- Telavi Referral Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LTD Unimed Kakheti- Telavi Referral Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".